APICES: Automatic PredICtion of Edema After Stroke

Sponsor
University Hospital Tuebingen (Other)
Overall Status
Recruiting
CT.gov ID
NCT04057690
Collaborator
(none)
1,500
1
48
31.3

Study Details

Study Description

Brief Summary

To use machine learning for early detection of malignant brain edema in patients with MCA ischemia

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Malignant cerebral edema following large ischemic strokes account for up to 10% of all ischemic strokes. Mortality rates are high and most of the survivors are left severely disabled. Although decompressive craniectomy has been shown to significantly decrease mortality, high morbidity rates among survivors are reported. The optimal timepoint when neurosurgical decompression should be performed in the individual patient varies and is a subject of debate.

    Early prediction of malignant brain edema to identify those patients who benefit from surgical treatment is a clinical challenge. The aim of this study is to use machine learning for comprehensive analysis of CT images as well as clinical data from 1500 patients with large ischemic MCA strokes in oder to develop a model for early prediction of malignant brain edema. In a first step algorithms automatically identify characteristic imaging features and clinical data of 1400 retrospective data sets to create a multistage model (learning phase). This is followed by a validation phase where the model is tested with 100 other retrospective data sets.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1500 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Automatic Prediction of Malignant Brain Edema After Middle Cerebral Artery Ischemic -Stroke
    Actual Study Start Date :
    Apr 1, 2019
    Anticipated Primary Completion Date :
    Dec 31, 2021
    Anticipated Study Completion Date :
    Mar 31, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    MCA ischemia without malignant edema

    MCA ischemia without malignant edema

    MCA ischemia with malignant edema

    MCA ischemia without malignant edema w/o surgical treatment

    Outcome Measures

    Primary Outcome Measures

    1. Number of patients with stroke-related malignant edema after recanalization treatment detected by deep learning algorithms [4/2019-3/2022]

      Deep learning algorithms will be used for automatic identification of specific image findings and specific clinical data that indicate a stroke-related malignant edema. Primary outcome measures are Sensitivity/Specificity/negative predictive value/positive predictive value of early detection of patients developing stroke-related malignant edema based on initial CT and 24 hour follow up CT and clinical parameters.

    Secondary Outcome Measures

    1. Number of correctly identified specific imaging findings for early detection of malignant edema [4/2019-3/2022]

      Used specific imaging findings for early detection of malignant brain edema are Collateral status, Clot Burden Score, Vein Score, Change in CSF volume. In this study the specific image findings are manually annotated and also automatically detected using deep learning algorithms. Secondary outcome measures are Sensitivity/Specificity/NPV/PPV of specific imaging findings identified by deep learning algorithms.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Acute ≥ subtotal MCA infarct (M1-M2 occlusion)

    • with or without malignant brain swelling

    • with or without reperfusion therapy

    • with or without neurosurgical decompression

    • with or without death following malignant brain edema

    Exclusion Criteria:
    • Non-acute MCA infarct

    • < subtotal MCA infarct

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital Tuebingen Tuebingen Germany 72076

    Sponsors and Collaborators

    • University Hospital Tuebingen

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital Tuebingen
    ClinicalTrials.gov Identifier:
    NCT04057690
    Other Study ID Numbers:
    • APICES
    First Posted:
    Aug 15, 2019
    Last Update Posted:
    May 3, 2021
    Last Verified:
    Nov 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital Tuebingen
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2021